Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sodium-Glucose Co-Transporter-2 Inhibitors as Adjuvant Therapy With Letrozole in Induction of Ovulation in Women With Polycystic Ovarian Syndrome

NCT07589075 is registered in ClinicalTrials.gov with Beni-Suef University as lead sponsor.

NCT NCT07589075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07589075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sodium-Glucose Co-Transporter-2 Inhibitors as Adjuvant Therapy With Letrozole in Induction of Ovulation in Women With Polycystic Ovarian Syndrome
Lead sponsor
Beni-Suef University
Phase
Phase 4
Overall status
Completed
Start date
October 20, 2023
Completion date
October 30, 2025
Enrollment
500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

induction of ovulation, pco - polycystic ovaries